D.E. Shaw & Co’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-797,567
| Closed | -$85.6M | – | 3508 |
|
|
2023
Q1 | $85.6M | Buy |
797,567
+72,338
| +10% | +$7.76M | 0.09% | 166 |
|
|
2022
Q4 | $79.8M | Buy |
725,229
+563,848
| +349% | +$62M | 0.09% | 153 |
|
|
2022
Q3 | $9.52M | Buy |
161,381
+117,360
| +267% | +$6.93M | 0.01% | 929 |
|
|
2022
Q2 | $1.24M | Sell |
44,021
-24,882
| -36% | -$703K | ﹤0.01% | 2569 |
|
|
2022
Q1 | $2.6M | Buy |
68,903
+52,432
| +318% | +$1.98M | ﹤0.01% | 2237 |
|
|
2021
Q4 | $651K | Buy |
+16,471
| New | +$651K | ﹤0.01% | 2967 |
|